Environmental risk assessment and management of veterinary medicines

Veterinary Medicines in the Environment

Volumn , Issue , 2016, Pages 21-55

  de Knecht, Joop ^a   Boucard, Tatiana ^b   Brooks, Bryan W ^c   Crane, Mark ^d   Eirkson, Charles ^e   Gerould, Sarah ^f   Koschorreck, Jan ^g   Scheef, Gregor ^h   Solomon, Keith R ⁱ   Yan, Zhixing ^j  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ENVIRONMENT AGENCY   (United Kingdom)

^c BAYLOR UNIVERSITY   (United States)

^d Watts Crane Associates   (United Kingdom)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f U S GEOLOGICAL SURVEY   (United States)

^g UMWELTBUNDESAMT   (Germany)

^h Intervet Innovation GmbH   (Germany)

ⁱ UNIVERSITY OF GUELPH   (Canada)

^j BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85122775271     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (49)

1. Anon. 2000. Termites and the public: attitude toward pesticides. Pest Cont Technol 28:50-52.
2. Arnold JG, Fohrer N. 2005. SWAT2000: current capabilities and research opportunities in applied watershed modeling. Hydrol Process 19:563-572.
3. Backhaus T, Altenburger R, Arrhenius A, Blanck H, Faust M, Finizio A, Gramatica P, Grote M, Junghans M, Meyer W, Pavan M, Porsbring T, Scholze M, Todeschini R, Vighi M, Walter H, Grimme LH. 2003. The BEAM-project: prediction and assessment of mixture toxicities in the aquatic environment. Cont Shelf Res 23:1757-1769.
4. Boxall ABA, Fogg LA, Blackwell PA, Kay P, Pemberton EJ, Croxford A. 2004. Veterinary medicines in the environment. Rev Environ Contam Toxicol 180:1-91.
5. Boxall ABA, Sherratt TN, Pudner V, Pope, LJ. 2007. A screening level index for assessing the impacts of veterinary medicines on dung flies. Environ Sci Technol 41:2630-2635.
6. Brooks BW, Riley TM, Taylor RD. 2006. Water quality of effluent-dominated stream ecosystems: ecotoxicological, hydrological, and management considerations. Hydrobiologia 556:365-379.
7. Brooks BW, Stanley JK, White JC, Turner PK, Wu KB, La Point TW. 2004. Laboratory and field responses to cadmium in effluent-dominated stream mesocosms. Environ Toxicol Chem 24:464-469.
8. Burmaster DE, Wilson AM. 1996. An introduction to second-order random variables in human health risk assessments. Hum Ecol Risk Ass 2:892-919.
9. Calow P. 1998. Ecological risk assessment: risk for what? How do we decide? Ecotoxicol Environ Safety 40:15-18.
10. Crane M, Grosso A, Janssen C. 1999. Statistical techniques for the ecological risk assessment of chemicals in freshwaters. In: Sparkes T, editor. Statistics in ecotoxicology. Chichester (UK): John Wiley, p 247-278.
11. Crane M, Norton A, Leaman J, Chalak A, Bailey A, Yoxon M, Smith J, Fenlon. 2006. Acceptability of pesticide impacts on the environment: what do United Kingdom stakeholders and the public value? Pest Man Sci 62:5-19.
12. Defra. 2004. Explanatory memorandum to statutory instruments. The controls on nonylphenol and nonylphenol ethoxylate regulations 2004, SI 2004 No. 1816. Department for the Environment, Food and Rural Affairs, London, UK. www.opsi.gov.uk/si/em2004/uksiem_20041816_en.pdf.
13. Douglas H. 2000. Inductive risk and values in science. Philos Sci 67:559-579.
14. Dunlap RE, Beus CE. 1992. Understanding public concerns about pesticides: an empirical examination. J Consumer Affairs 26:418-438.
15. [EC] European Commission. 1990. Council Directive 90/676/EEC of 13 December 1990 amending Directive 81/851/EEC on the approximation of the laws of the Member States relating to veterinary medicinal products Official Journal L373, 31.12.1990.
16. [EC] European Commission. 1993. Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products. Official Journal L214, 24/08/1993.
17. [EMEA] European Agency for the Evaluation of Medicinal Products. 1998. Note for Guidance: Environmental risk assessment for veterinary medicinal products other than GMO-containing and immunological products. London, UK: European Agency for the Evaluation of Medicinal Products. Rapport nr. EMEA/CVMP/055/96.
18. [EMEA] European Agency for the Evaluation of Medicinal Products. 2001. Discussion paper on environmental risk assessment of non-genetically modified organism (non-GMO) containing medicinal products for human use. CPMP/SWP/4447/00 draft corr. London (UK): European Agency for the Evaluation of Medicinal Products.
19. [EMEA] European Agency for the Evaluation of Medicinal Products. 2003. Note for guidance on environmental risk assessment of medicinal products for human use. CPMP/SWP/4447/00 draft. London (UK): European Agency for the Evaluation of Medicinal Products.
20. [EMEA] European Agency for the Evaluation of Medicinal Products. 2005. Guideline on the environmental risk assessment of medicinal products for human use. CHMP/ SWP/ 4447/00 draft. London (UK): European Agency for the Evaluation of Medicinal Products.
21. European Crop Protection Association. N.d. http://www.ecpa.be.
22. European Parliament. 2001a. Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to veterinary medicinal products. Official Journal L 311, 28/11/2001, p 0001-0066. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev1.htm.
23. European Parliament. 2001b. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use. Official Journal L 311, 28/11/2001, p 0067-0128. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev1.htm.
24. European Parliament. 2004a. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the community code relating to medicinal products for human use. Official Journal L 136, 30/04/2004, p 0034-0057. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev1.htm
25. European Parliament. 2004b. Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/82/EC on the community code relating to veterinary medicinal products. Official Journal L 136, 30/04/2004, p 0058-0084. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0058:0084:EN:PDF.
26. European Parliament. 2004c. Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Official Journal L 136, 30/04/2004, p 0001-0033. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/reg_2004_726/reg_2004_726_en.pdf.
27. Frewer L. 2003. Societal issues and public attitudes towards genetically modified foods. Trends Food Sci Technol 14:319-332.
28. Frewer L. 2004. The public and effective risk communication. Toxicol Lett 149:391-397.
29. Frewer L, Lassen J, Kettlitz B, Scholderer J, Beekman V, Berdal KG. 2004. Societal aspects of genetically modified foods. Food Chem Toxicol 42:1181-1193.
30. Geary PM, Davies CM. 2003. Bacterial source tracking and shellfish contamination in a coastal catchment. Wat Sci Technol 47:95-100.
31. Hansen J, Holm L, Frewer L, Robinson P, Sandoe P. 2003. Beyond the knowledge deficit: recent research into lay and expert attitudes to food risks. Appetite 41:111-121.
32. Junghans M, Backhaus T, Faust M, Scholze M, Grimme LH. 2006. Application and validation of approaches for the predictive hazard assessment of realistic pesticide mixtures. Aquatic Toxicol 76:93-110.
33. McFarland AMS, Hauck LM. 1999. Relating agricultural land uses to in-stream storm-water quality. Journal of Environmental Quality 28:836-844.
34. National Archives and Records Administration. 2004. Code of federal regulations. http://www.access.gpo.gov/nara/cfr/waisidx_01/21cfr25_01.html.
35. National Environmental Policy Act. 1969. NEPA, the National Environmental Policy Act [42 U.S.C.4321 et seq.].
36. Orlando EF, Kolok AS, Binzcik GA, Gates JL, Horton MK, Lambright CS, Gray LE Jr, Soto AM, Guillette L Jr. 2004. Endocrine-disrupting effects of cattle feedlot effluent on an aquatic sentinel species, the fathead minnow. Environ Health Perspect 112:353-358.
37. Perrow C. 1999. Normal accidents: living with high-risk technologies. Princeton (NJ): Princeton University Press.
38. Posthuma L, Suter GW, Traas TP, editors. 2002. Species sensitivity distributions in ecotoxicology. Boca Raton (FL): Lewis.
39. Slovic P. 2000. The perception of risk. London (UK): Earthscan.
40. Tait J. 2001a. More Faust than Frankenstein: the European debate about the precautionary principle and risk regulation for genetically modified crops. J Risk Res 4:175-189.
41. Tait J. 2001b. Pesticide regulation, product innovation and public attitudes. J Environ Monitor 3:64N-69N.
42. Tait J, Bruce A, Lyall C. 2001. Studies on people's values in relation to chemicals and their effects on humans and the natural environment: a literature review. Report to the Royal Commission on Environmental Pollution. SUPRA Paper 23. Edinburgh (Scotland): Royal Commission on Environmental Pollution.
43. Texas Commission on Environmental Quality. N.d. http://www.tceq.state.tx.us.
44. [USEPA] US Environmental Protection Agency. 1997. Guiding principles for Monte Carlo analysis. EPA/630/R-97/001, Risk Assessment Forum. Washington (DC): US Environmental Protection Agency. http://www.epa.gov/ncea/raf/montecar.pdf.
45. [USEPA] US Environmental Protection Agency. 1999. Report of the workshop on selecting input distributions for probabilistic assessments. EPA/630/R-98/004, Risk Assessment Forum. Washington (DC): US Environmental Protection Agency.
46. [VICH] International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products. 2002. Environmental impact assessment (EIAs) for veterinary medicinal products (veterinary medicines) - phase I. VICH GL6 (ecotoxicity phase 1) June. http://vich.eudra.org.
47. [VICH] International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products. 2004. Environmental impact assessment (EIAs) for veterinary medicinal products (veterinary medicines) - phase II. VICH GL38 (ecotoxicity phase II) October. http://vich.eudra.org.
48. [VMD] 2005. Sales of Antimicrobial Products Authorized for Use as Veterinary Medicines, Antiprotozoals, Antifungals, Growth Promoters, and Coccidiostats, in the UK in 2004. Veterinary Medicines Directorate, Addlestone, UK.
49. Warren-Hicks WJ, Moore DRJ. 1998. Uncertainty analysis in ecological risk assessment. Pensacola (FL): SETAC Press.